Literature DB >> 1316452

Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions.

W A Shah1, R F Ambinder, G S Hayward, S D Hayward.   

Abstract

The Epstein-Barr virus nuclear antigen EBNA-1 is essential for replication of the viral DNA during latency. EBNA-1 binds as a dimer to palindromic recognition sequences within the plasmid origin of replication, ori-P. In this study, proteinase K susceptibility has been used to further characterize the DNA-binding domain of EBNA-1. Limited protease digestion of EBNA-1 (amino acids 408 to 641) generated a smaller DNA-binding species that had a degree of inherent protease resistance. When EBNA-1 was preincubated with a specific DNA probe, the protease resistance of the smaller binding species increased 100-fold, suggesting that the conformation of EBNA-1 changes on binding. The protease-resistant species comprised an 18-kDa polypeptide that was further cleaved at high levels of protease to 11- and 5.4-kDa products. A model of the proposed protease-resistant domain structure is presented. Constructions carrying serial, internal deletions across the 18-kDa domain were created. Each of the deletions perturbed dimerization ability and abolished DNA binding. These studies suggest that the DNA-binding and dimerization motifs of EBNA-1 lie within a conformationally discrete domain whose overall integrity is necessary for EBNA-1-DNA interaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316452      PMCID: PMC241114     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.

Authors:  J Sample; L Brooks; C Sample; L Young; M Rowe; C Gregory; A Rickinson; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

2.  Functional domains of Epstein-Barr virus nuclear antigen EBNA-1.

Authors:  R F Ambinder; M A Mullen; Y N Chang; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus.

Authors:  L Frappier; M O'Donnell
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

4.  Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins.

Authors:  T Williams; R Tjian
Journal:  Science       Date:  1991-03-01       Impact factor: 47.728

Review 5.  Lambda repressor: a model system for understanding protein-DNA interactions and protein stability.

Authors:  R T Sauer; S R Jordan; C O Pabo
Journal:  Adv Protein Chem       Date:  1990

6.  Identification of precursor to cytomegalovirus capsid assembly protein and evidence that processing results in loss of its carboxy-terminal end.

Authors:  W Gibson; A I Marcy; J C Comolli; J Lee
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.

Authors:  J Yates; N Warren; D Reisman; B Sugden
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif.

Authors:  Y N Chang; D L Dong; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

9.  Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA.

Authors:  M A Weiss; T Ellenberger; C R Wobbe; J P Lee; S C Harrison; K Struhl
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

10.  Two distinct domains in the yeast transcription factor IID and evidence for a TATA box-induced conformational change.

Authors:  P M Lieberman; M C Schmidt; C C Kao; A J Berk
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

View more
  11 in total

1.  Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.

Authors:  A L Kirchmaier; B Sugden
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

2.  Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.

Authors:  Kimberly A Malecka; Jayaraju Dheekollu; Julianna S Deakyne; Andreas Wiedmer; Ursula D Ramirez; Paul M Lieberman; Troy E Messick
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

3.  Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication.

Authors:  K Goldsmith; L Bendell; L Frappier
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure.

Authors:  M R Chen; J M Middeldorp; S D Hayward
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.

Authors:  Eun Kyung Lee; Sun Young Kim; Ka-Won Noh; Eun Hye Joo; Bo Zhao; Elliott Kieff; Myung-Soo Kang
Journal:  Antiviral Res       Date:  2014-01-31       Impact factor: 5.970

6.  Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function.

Authors:  Sarah J Duellman; Katie L Thompson; Joshua J Coon; Richard R Burgess
Journal:  J Gen Virol       Date:  2009-05-13       Impact factor: 3.891

Review 7.  Immune regulation in Epstein-Barr virus-associated diseases.

Authors:  R Khanna; S R Burrows; D J Moss
Journal:  Microbiol Rev       Date:  1995-09

8.  Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

Authors:  C Münz; K L Bickham; M Subklewe; M L Tsang; A Chahroudi; M G Kurilla; D Zhang; M O'Donnell; R M Steinman
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

Review 9.  Epstein-Barr virus latent genes.

Authors:  Myung-Soo Kang; Elliott Kieff
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

Review 10.  The Epstein-Barr Virus EBNA1 Protein.

Authors:  Lori Frappier
Journal:  Scientifica (Cairo)       Date:  2012-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.